WHO panel: Prioritize drugs for Ebola efficacy trials
This article was originally published in Scrip
Executive Summary
With several drugs now on the fast-track to be tested for their effectiveness against Ebola, a panel of experts from the World Health Organization (WHO) said certain factors should be considered in determining which medicines should first undergo efficacy evaluations.